Plus Therapeutics appoints Russell Bradley as president, CNSide

Plus Therapeutics (PSTV) announced that is has appointed Russell Bradley as the President and General Manager of its wholly-owned subsidiary, CNSide Diagnostics. Furthermore, Plus has also appointed Dr. Marc Hedrick, Rick Hawkins, and Russell Bradley to the CNSide Board of Directors, and Dr. Jonathan Stein has been named CNSide Medical Director. Bradley brings over 30 years of leadership experience in diagnostics and life sciences, having held senior executive roles at Abbott Laboratories, Luminex Corporation, and Beckman Coulter. Stein served as Medical Director at Gene By Gene and as a Research Investigator at M.D. Anderson Cancer Center.